GENMARK DIAGNOSTICS INC - COM (GNMK)

CUSIP: 372309104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
53,203,068
Share change
-779,241
Total reported value
$258,565,571
Price per share
$4.86
Number of holders
101
Value change
-$14,356,748
Number of buys
46
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 372309104?
CUSIP 372309104 identifies GNMK - GENMARK DIAGNOSTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q4 2018

As of 31 Dec 2018, GENMARK DIAGNOSTICS INC - COM (GNMK) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,203,068 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, CADIAN CAPITAL MANAGEMENT, LP, Casdin Capital, LLC, JPMORGAN CHASE & CO, BlackRock Inc., Vanguard Group Inc, HighTower Advisors, LLC, Bellevue Group AG, and BANK OF AMERICA CORP /DE/. This page lists 101 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.